PhotoPharmics Achieves 50% Enrollment in Pioneering Phase 3 Parkinson’s Trial
Advancing Light Therapy Research to Enhance Quality of Life for Parkinson’s Patients SALT LAKE CITY, UT, UNITED STATES, February 7, 2025 /EINPresswire.com/ -- PhotoPharmics, a leader in non-invasive therapeutic light therapy, announced today that it has …